14
Participants
Start Date
March 25, 2019
Primary Completion Date
April 5, 2019
Study Completion Date
CTP-543
Once daily dosing
Celerion, Inc., Tempe
Lead Sponsor
Concert Pharmaceuticals
INDUSTRY